drugset / Trial / NCT00748371
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
RandomizedParallel-groupDouble-blindBasic science
Summary
Aspirin has shown to be beneficial to some patients with certain diseases such as coronary artery disease or stroke. We are investigating how aspirin works on regulating platelets and thromboxane over time at different doses. We hope to find the best dose of aspirin and/or other medications to help people who are at risk for heart attack or stroke.
Timeline
- Start
- 2004-06
- Primary completion
- 2011-02
- Completion
- 2011-02
Outcome
Outcome not reported
Stopped (Business): “Funding issue”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 40 mg | Oral |
| Subject | Aspirin | Small molecule | 1300 mg | Oral |